An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants

被引:26
作者
Tallei, Trina Ekawati [1 ,2 ]
Fatimawali [2 ,3 ]
Yelnetty, Afriza [4 ]
Idroes, Rinaldi [5 ]
Kusumawaty, Diah [6 ]
Bin Emran, Talha [7 ]
Yesiloglu, Talha Zahid [8 ]
Sippl, Wolfgang [8 ]
Mahmud, Shafi [9 ]
Alqahtani, Taha [10 ]
Alqahtani, Ali M. [10 ]
Asiri, Saeed [11 ]
Rahmatullah, Mohammed [12 ]
Jahan, Rownak [12 ]
Khan, Md Arif [12 ]
Celik, Ismail [13 ]
机构
[1] Sam Ratulangi Univ, Fac Math & Nat Sci, Dept Biol, Manado, Indonesia
[2] Sam Ratulangi Univ, Univ Ctr Excellence Biotechnol & Conservat Wallac, Inst Res & Community Serv, Manado, Indonesia
[3] Sam Ratulangi Univ, Fac Math & Nat Sci, Pharm Study Program, Manado, Indonesia
[4] Sam Ratulangi Univ, Fac Anim Husb, Dept Anim Prod, Manado, Indonesia
[5] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Pharm, Banda Aceh, Indonesia
[6] Univ Pendidikan Indonesia, Fac Math & Nat Sci Educ, Dept Biol, Bandung, Indonesia
[7] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong, Bangladesh
[8] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Germany
[9] Univ Rajshahi, Dept Genet Engn & Biotechnol, Microbiol Lab, Rajshahi, Bangladesh
[10] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha, Saudi Arabia
[11] Najran Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Najran, Saudi Arabia
[12] Univ Dev Alternat, Dept Biotechnol & Genet Engn, Dhaka, Bangladesh
[13] Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, Kayseri, Turkey
关键词
bromelain; receptor-binding domain; SARS-CoV-2; mutation; variants; WEB SERVER; BINDING-AFFINITY; PROTEIN; CLUSPRO; VIRUS;
D O I
10.3389/fphar.2021.717757
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 angstrom. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required.
引用
收藏
页数:18
相关论文
共 63 条
  • [41] UCSF chimera - A visualization system for exploratory research and analysis
    Pettersen, EF
    Goddard, TD
    Huang, CC
    Couch, GS
    Greenblatt, DM
    Meng, EC
    Ferrin, TE
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) : 1605 - 1612
  • [42] Drug targets for corona virus: A systematic review
    Prajapat, Manisha
    Sarma, Phulen
    Shekhar, Nishant
    Avti, Pramod
    Sinha, Shweta
    Kaur, Hardeep
    Kumar, Subodh
    Bhattacharyya, Anusuya
    Kumar, Harish
    Bansal, Seema
    Medhi, Bikash
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (01) : 56 - 65
  • [43] Salt Bridge in Aqueous Solution: Strong Structural Motifs but Weak Enthalpic Effect
    Pylaeva, Svetlana
    Brehm, Martin
    Sebastiani, Daniel
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [44] Potential role of bromelain in clinical and therapeutic applications
    Rathnavelu, Vidhya
    Alitheen, Noorjahan Banu
    Sohila, Subramaniam
    Kanagesan, Samikannu
    Ramesh, Rajendran
    [J]. BIOMEDICAL REPORTS, 2016, 5 (03) : 283 - 288
  • [45] Saedi Jami M., 2013, Adv. Enzym. Res, V01, P52, DOI [10.4236/aer.2013.13006, DOI 10.4236/AER.2013.13006]
  • [46] Sagar Satish, 2020, bioRxiv, DOI 10.1101/2020.09.16.297366
  • [47] In silicoanalysis of protein/peptide-based inhalers against SARS-CoV-2
    Salman, Saad
    Shah, Fahad Hassan
    Chaudhry, Maham
    Tariq, Muniba
    Akbar, Muhammad Yasir
    Adnan, Muhammad
    [J]. FUTURE VIROLOGY, 2020, 15 (09) : 557 - 564
  • [48] Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
    Salomon-Ferrer, Romelia
    Goetz, Andreas W.
    Poole, Duncan
    Le Grand, Scott
    Walker, Ross C.
    [J]. JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2013, 9 (09) : 3878 - 3888
  • [49] Schütz D, 2020, ADV DRUG DELIVER REV, V167, P47, DOI 10.1016/j.addr.2020.11.007
  • [50] SWISS-MODEL: an automated protein homology-modeling server
    Schwede, T
    Kopp, J
    Guex, N
    Peitsch, MC
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (13) : 3381 - 3385